These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 22678114)

  • 1. Epithelial-mesenchymal transition increases tumor sensitivity to COX-2 inhibition by apricoxib.
    Kirane A; Toombs JE; Larsen JE; Ostapoff KT; Meshaw KR; Zaknoen S; Brekken RA; Burrows FJ
    Carcinogenesis; 2012 Sep; 33(9):1639-46. PubMed ID: 22678114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apricoxib, a novel inhibitor of COX-2, markedly improves standard therapy response in molecularly defined models of pancreatic cancer.
    Kirane A; Toombs JE; Ostapoff K; Carbon JG; Zaknoen S; Braunfeld J; Schwarz RE; Burrows FJ; Brekken RA
    Clin Cancer Res; 2012 Sep; 18(18):5031-42. PubMed ID: 22829202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apricoxib upregulates 15-PGDH and PGT in tobacco-related epithelial malignancies.
    St John MA; Wang G; Luo J; Dohadwala M; Hu D; Lin Y; Dennis M; Lee JM; Elashoff D; Lawhon T; Zaknoen SL; Burrows FJ; Dubinett SM
    Br J Cancer; 2012 Aug; 107(4):707-12. PubMed ID: 22828609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination Treatment with Apricoxib and IL-27 Enhances Inhibition of Epithelial-Mesenchymal Transition in Human Lung Cancer Cells through a STAT1 Dominant Pathway.
    Lee MH; Kachroo P; Pagano PC; Yanagawa J; Wang G; Walser TC; Krysan K; Sharma S; John MS; Dubinett SM; Lee JM
    J Cancer Sci Ther; 2014 Nov; 6(11):468-477. PubMed ID: 26523208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor and anti-metastatic effects of cyclooxygenase-2 inhibition by celecoxib on human colorectal carcinoma xenografts in nude mouse rectum.
    Ninomiya I; Nagai N; Oyama K; Hayashi H; Tajima H; Kitagawa H; Fushida S; Fujimura T; Ohta T
    Oncol Rep; 2012 Sep; 28(3):777-84. PubMed ID: 22751903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient synthesis of apricoxib, CS-706, a selective cyclooxygenase-2 inhibitor, and evaluation of inhibition of prostaglandin E2 production in inflammatory breast cancer cells.
    Mandal PK; Freiter EM; Bagsby AL; Robertson FM; McMurray JS
    Bioorg Med Chem Lett; 2011 Oct; 21(20):6071-3. PubMed ID: 21903394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apricoxib, a COX-2 inhibitor for the potential treatment of pain and cancer.
    Rao PN; Grover RK
    IDrugs; 2009 Nov; 12(11):711-22. PubMed ID: 19844858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo inhibitory effect of three Cox-2 inhibitors and epithelial-to-mesenchymal transition in human bladder cancer cell lines.
    Adhim Z; Matsuoka T; Bito T; Shigemura K; Lee KM; Kawabata M; Fujisawa M; Nibu K; Shirakawa T
    Br J Cancer; 2011 Jul; 105(3):393-402. PubMed ID: 21750550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of PGE2 by physiologic levels of celecoxib is not sufficient to induce apoptosis or inhibit cell proliferation in human colon carcinoma cell lines.
    Lev-Ari S; Kazanov D; Liberman E; Ben-Yosef R; Arber N
    Dig Dis Sci; 2007 Apr; 52(4):1128-33. PubMed ID: 17342386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restoration of E-cadherin expression by selective Cox-2 inhibition and the clinical relevance of the epithelial-to-mesenchymal transition in head and neck squamous cell carcinoma.
    Fujii R; Imanishi Y; Shibata K; Sakai N; Sakamoto K; Shigetomi S; Habu N; Otsuka K; Sato Y; Watanabe Y; Ozawa H; Tomita T; Kameyama K; Fujii M; Ogawa K
    J Exp Clin Cancer Res; 2014 May; 33(1):40. PubMed ID: 24887090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cyclooxygenase-2 (COX-2) selective non-steroidal anti-inflammatory drug enhances the growth inhibitory effect of butyrate in colorectal carcinoma cells expressing COX-2 protein: regulation of COX-2 by butyrate.
    Crew TE; Elder DJ; Paraskeva C
    Carcinogenesis; 2000 Jan; 21(1):69-77. PubMed ID: 10607736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined cetuximab and celecoxib treatment exhibits a synergistic anticancer effect on human oral squamous cell carcinoma in vitro and in vivo.
    Qian M; Qian D; Jing H; Li Y; Ma C; Zhou Y
    Oncol Rep; 2014 Oct; 32(4):1681-8. PubMed ID: 25328959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Green tea catechins reduce invasive potential of human melanoma cells by targeting COX-2, PGE2 receptors and epithelial-to-mesenchymal transition.
    Singh T; Katiyar SK
    PLoS One; 2011; 6(10):e25224. PubMed ID: 22022384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective Cox-2 inhibitor celecoxib induces epithelial-mesenchymal transition in human lung cancer cells via activating MEK-ERK signaling.
    Wang ZL; Fan ZQ; Jiang HD; Qu JM
    Carcinogenesis; 2013 Mar; 34(3):638-46. PubMed ID: 23172668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological inhibition of platelet-tumor cell cross-talk prevents platelet-induced overexpression of cyclooxygenase-2 in HT29 human colon carcinoma cells.
    Dovizio M; Maier TJ; Alberti S; Di Francesco L; Marcantoni E; M√ľnch G; John CM; Suess B; Sgambato A; Steinhilber D; Patrignani P
    Mol Pharmacol; 2013 Jul; 84(1):25-40. PubMed ID: 23580446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Celecoxib inhibits tumor growth and angiogenesis in an orthotopic implantation tumor model of human colon cancer.
    Wang L; Chen W; Xie X; He Y; Bai X
    Exp Oncol; 2008 Mar; 30(1):42-51. PubMed ID: 18438340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Celecoxib inactivates epithelial-mesenchymal transition stimulated by hypoxia and/or epidermal growth factor in colon cancer cells.
    Bocca C; Bozzo F; Cannito S; Parola M; Miglietta A
    Mol Carcinog; 2012 Oct; 51(10):783-95. PubMed ID: 21882253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The COX-2 selective inhibitor-independent COX-2 effect on colon carcinoma cells is associated with the Delta1/Notch1 pathway.
    Zhang H; Ye Y; Bai Z; Wang S
    Dig Dis Sci; 2008 Aug; 53(8):2195-203. PubMed ID: 18320325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophages programmed by apoptotic cells inhibit epithelial-mesenchymal transition in lung alveolar epithelial cells via PGE2, PGD2, and HGF.
    Yoon YS; Lee YJ; Choi YH; Park YM; Kang JL
    Sci Rep; 2016 Feb; 6():20992. PubMed ID: 26875548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Palbociclib inhibits epithelial-mesenchymal transition and metastasis in breast cancer via c-Jun/COX-2 signaling pathway.
    Qin G; Xu F; Qin T; Zheng Q; Shi D; Xia W; Tian Y; Tang Y; Wang J; Xiao X; Deng W; Wang S
    Oncotarget; 2015 Dec; 6(39):41794-808. PubMed ID: 26540629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.